AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis

Published:2008-10 Issue:10 Volume:36 Page:1337-1342
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Fukushima-Shintani Mari,Suzuki Ken-ichi,Iwatsuki Yoshiyuki,Abe Masaki,Sugasawa Keizo,Hirayama Fukushi,Kawasaki Tomihisa

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference20 articles.

1. Thrombopoietin;Kaushansky;N Engl J Med,1998

2. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production;Kaushansky;Oncogene,2002

3. Thrombocytopenia caused by the development of antibodies to thrombopoietin;Li;Blood,2001

4. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor;Basser;Blood,2002

5. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer;Vadhan-Raj;Ann Intern Med,1997

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombopoietin Receptor Agonists in Post-Hematopoietic Cell Transplantation Complicated by Prolonged Thrombocytopenia: A Comprehensive Review;ImmunoTargets and Therapy;2024-09

2. Avatrombopag as alternative therapy for severe aplastic anemia patients who are intolerant or unresponsive to eltrombopag;Frontiers in Immunology;2024-07-24

3. Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China;British Journal of Haematology;2024-02-16

4. Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials;BMJ Open;2024-01

5. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently;Frontiers in Cardiovascular Medicine;2023-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3